Aldehyde Dehydrogenase 5 Family Member A1 (ALDH5A1) Antibody

Este producto es parte de ALDH - Aldehyde dehydrogenase family member
Product Graph
637€ (100 µl)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
Aldehyde Dehydrogenase 5 Family Member A1 (ALDH5A1) Antibody
category
Primary Antibodies
provider
Abbexa
reference
abx110920
tested applications
ELISA, WB

Description

Aldehyde Dehydrogenase 5 Family, Member A1 Antibody is a Rabbit Polyclonal antibody against Aldehyde Dehydrogenase 5 Family, Member A1.

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

CategoryPrimary Antibodies
Immunogen TargetAldehyde Dehydrogenase 5 Family Member A1 (ALDH5A1)
HostRabbit
ReactivityHuman, Mouse, Rat
Recommended DilutionOptimal dilutions/concentrations should be determined by the end user.
ClonalityPolyclonal
ConjugationUnconjugated
IsotypeIgG
PurificationAntigen Affinity Chromatography.
Size 1100 µl
FormLiquid
Tested ApplicationsELISA, WB
BufferPBS, pH 7.3, containing 0.1% Sodium Azide and 50% Glycerol.
AvailabilityShipped within 5-10 working days.
StorageAliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
Dry IceNo
UniProt IDP51649
Gene ID7915
NCBI AccessionNP_001071.1, NM_001080.3, NP_733936.1, NM_170740.1
OMIM271980
AliasALDH5A1,SSADH
BackgroundAntibody anti-ALDH5A1
StatusRUO

Descripción

ALDH5A1, also known as succinic semialdehyde dehydrogenase (SSADH), is a mitochondrial enzyme involved in the catabolism of gamma-aminobutyric acid (GABA), an important inhibitory neurotransmitter. ALDH5A1 catalyzes the oxidation of succinic semialdehyde (SSA) to succinate, a key intermediate in the tricarboxylic acid (TCA) cycle, linking GABA metabolism to cellular energy production. Mutations in ALDH5A1 result in succinic semialdehyde dehydrogenase deficiency, a rare autosomal recessive disorder that causes the accumulation of SSA and GABA, leading to neurological symptoms such as developmental delays, hypotonia, seizures, and ataxia. ALDH5A1 plays a crucial role in maintaining GABA homeostasis and preventing neurotoxicity. Its dysfunction highlights the importance of proper neurotransmitter balance and energy metabolism in neurological health. Therapies targeting ALDH5A1 function focus on reducing SSA accumulation and alleviating associated neurological impairments.

Related Products

EH1288

Human ALDH5A1(Succinate-semialdehyde dehydrogenase, mitochondrial) ELISA Kit

Ver Producto
FNab00297

anti- ALDH5A1 antibody

Catalyzes one step in the degradation of the inhibitory neurotransmitter gamma-aminobutyric acid(GABA).

Ver Producto
P5328

Recombinant Human ALDH5A1

Ver Producto